| Year |
Citation |
Score |
| 2019 |
Lhomme S, DebRoy S, Kamar N, Abravanel F, Metsu D, Marion O, Dimeglio C, Cotler SJ, Izopet J, Dahari H. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin. Viruses. 11. PMID 31323954 DOI: 10.3390/V11070630 |
0.313 |
|
| 2017 |
DebRoy S, Prosper O, Mishoe A, Mubayi A. Challenges in modeling complexity of neglected tropical diseases: a review of dynamics of visceral leishmaniasis in resource limited settings. Emerging Themes in Epidemiology. 14: 10. PMID 28936226 DOI: 10.1186/S12982-017-0065-3 |
0.392 |
|
| 2016 |
DebRoy S, Hiraga N, Imamura M, Hayes CN, Akamatsu S, Canini L, Perelson AS, Pohl RT, Persiani S, Uprichard SL, Tateno C, Dahari H, Chayama K. Hepatitis C virus dynamics and cellular gene expression in uPA-SCID chimeric mice with humanized livers during intravenous silibinin monotherapy. Journal of Viral Hepatitis. PMID 27272497 DOI: 10.1111/Jvh.12551 |
0.388 |
|
| 2015 |
Canini L, DebRoy S, Mariño Z, Conway JM, Crespo G, Navasa M, D'Amato M, Ferenci P, Cotler SJ, Forns X, Perelson AS, Dahari H. Severity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapy. Antiviral Therapy. 20: 149-55. PMID 24912382 DOI: 10.3851/Imp2806 |
0.443 |
|
| 2013 |
DebRoy S, Mariño Z, Crespo G, Navasa M, D'Amato M, Cotler SJ, Forns X, Dahari H. 808 Modeling Hcv Kinetics During Intravenous Silibinin Monotherapy In The Peri-Transplant Period Journal of Hepatology. 58. DOI: 10.1016/S0168-8278(13)60810-7 |
0.356 |
|
| 2011 |
Debroy S, Bolker BM, Martcheva M. Bistability and long-term cure in a within-host model of hepatitis C Journal of Biological Systems. 19: 533-550. DOI: 10.1142/S0218339011004135 |
0.498 |
|
| 2010 |
DebRoy S, Kribs-Zaleta C, Mubayi A, Cardona-Meléndez GM, Medina-Rios L, Kang M, Diaz E. Evaluating treatment of hepatitis C for hemolytic anemia management. Mathematical Biosciences. 225: 141-55. PMID 20303990 DOI: 10.1016/J.Mbs.2010.02.005 |
0.416 |
|
| Show low-probability matches. |